Contraceptive Technology Update – April 1, 2003

April 1, 2003

• Hormone therapy: Make decisions on a balanced risk-to-benefit basis

  Family planning clinicians have found their care of postmenopausal women has changed dramatically since the July 2002 cessation of the estrogen/progestin arm of the Womens Health Initiative (WHI). The estrogen/progestin arm of the landmark study was halted after findings showed that the overall health risk, particularly of cardiovascular disease and breast cancer, from taking estrogens with progestin was greater than the benefits of lowering the risk of colon cancer and bone fractures.

  Read more about Hormone therapy: Make decisions on a balanced risk-to-benefit basis - Contraceptive Technology Update – April 1, 2003

• Use the web for hormone therapy information

  Check out the following Internet resources for more information on hormone therapy.

  Read more about Use the web for hormone therapy information

• Maintain confidential care for adolescents

  Your practice includes confidential care for adolescents, including provision of contraceptives and testing/treatment for sexually transmitted diseases (STDs). But are your office staff communicating the confidentiality of this information correctly to prospective teen patients? If they are not, adolescents may fail to access these important services.

  Read more about Maintain confidential care for adolescents - Contraceptive Technology Update – April 1, 2003

• The Pill and bone health: What is the impact?

  Combined oral contraceptives (OCs) help decrease a womans risk for epithelial ovarian cancer and endometrial cancer, reduce her risk of pelvic inflammatory disease and ectopic pregnancy, and lessen menstrual cramps and pain. But what is their impact on bone mineral density (BMD)?

  Read more about The Pill and bone health: What is the impact? - Contraceptive Technology Update – April 1, 2003

• Getting men on board: one facility’s approach

  If the number of men on your patient rosters is low, take a look at the approach used by Planned Parenthood of San Antonio and South Central Texas. In the first year of its marketing initiative, the number of its male patients nearly doubled from 2% to 3.7% of total patients served.

  Read more about Getting men on board: one facility’s approach - Contraceptive Technology Update – April 1, 2003

• Ask the Experts: Answers to questions on OC use, DMPA impact

  Whats the impact of concomitant medications on combined oral contraceptives (OCs)?

  Read more about Ask the Experts: Answers to questions on OC use, DMPA impact - Contraceptive Technology Update – April 1, 2003

• CTU Updates

  Enter abstracts for ARHP annual conference; New payment options announced for Mirena

  Read more about CTU Updates - Contraceptive Technology Update – April 1, 2003